Bear in mind there are subgroups.
In hour DD. Please share your conclusions. I don't really dabble in the science side to me its all about risk weightings.
My non scientific understanding is methylation in general helps repair DNA damage. So the unmethylated group respond better because they are not as good at repairing the DNA. That is the cancer DNA that TMZ attacks. PI3K is upregulated in about 85% of cases these groups may over lap but they are two different things. So say you are unmethylated and PI3K upregulated then both drugs may work. The adverse may also be true. There is no one drug that target all GBM at this stage. So there is room for many drugs.
- Forums
- ASX - By Stock
- KZA
- Ann: Kazia releases final data from P2 paxalisib trial
Ann: Kazia releases final data from P2 paxalisib trial, page-108
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online